Dan Oren
CIK 1636701 · last filed 2019-06-06
Dan Oren is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider bought $20.0M of MYOV on Jun 6, 2019. Across all open-market trades the lifetime net is +$20.3M, making them a net buyer over the disclosed history. 31 SEC filings were submitted jointly with Dexxon Holdings Ltd.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MYOV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
OR AKIVA, L3 30600000
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Myovant Sciences Ltd. (MYOV) Delisted | 10%+ Owner | 40,765,599 | $26.98 | $1.10B | $20.00M | 1 | 2019-06-06 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,777,338 | $16.24 | $369.90M | $301.8K | 3 | 2019-06-03 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| MYOV | Roivant Sciences Ltd See footnotes |
40,765,599 | 100.0% | 2019-06-06 |
| Total | 40,765,599 | |||
| UROV | Roivant Sciences Ltd See footnotes |
22,777,338 | 100.0% | 2019-06-03 |
| Total | 22,777,338 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-06 | Myovant Sciences Ltd. (MYOV) Delisted | Buy (P) | +2,424,242 | $20.00M | EDGAR |
| 2019-06-03 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +17,746 | $138.9K | EDGAR |
| 2019-05-22 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +10,000 | $80.5K | EDGAR |
| 2019-05-20 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +11,608 | $82.4K | EDGAR |
| 2019-03-19 | — | Buy (P) | +6,666,667 | $10.00M | |
| 2018-12-20 | — | Buy (P) | +10,000,000 | $10.00M |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).